Candesic

This week we bid a fond farewell – for now – to two hardworking interns who have really thrown themselves into their assignments this month and leave Candesic on a positive note.   The whole team wants to wish David O Abe and Raihaan Biju all the best on their new adventures.   David tells us: “I think what I enjoyed most was how solution focused the work was. It was great being able to analyze the business, but also soundly critique the science.   “Working here has changed my way of thinking about and analyzing problems within health care.”   Raihaan adds: “I found myself doing a significant amount of data exploration. It was good to understand the real, good work being done compared to the corporate glitz that can often be associated with consulting.   “I really liked the team aspect when you were on a project. There was a real sense of camaraderie at Candesic, and I got the sense that people here really like each other - I’ll miss that.”   Raihaan and David, always strive to exceed limits, maintain a sense of curiosity, and never underestimate your potential!   Candesic continues to offer a supportive environment to help the next generation of talent to thrive and grow. To find out more about opportunities here, go to https://lnkd.in/dfZ8WeZn   #SummerInterns #Careers #Healthcare

In the latest edition LaingBuisson HealthcareMarkets, Candesic Senior Partner Dr Michelle Tempest and Senior Engagement Manager Jack Zeng count the cost of fixing English NHS waiting list - literally.   The Candesic team has done a detailed analysis of the scale of the problem, broken down by composition and cost, working out the additional staffing requirements and the extent to which additional elective activity will need to be increased by the NHS and/or independents to meet target.   Whether you would like to see the detailed breakdown or just the final figures, click the article to read in full. If you would like to know more, message Michelle or Jack on LinkedIn, email talk@candesic.com or call +44 (0)20 7096 7680. #nhswaitinglist #ukhealthcare #nhs

An evening of inspiration and learning is on offer tomorrow for those looking to be part of the conversation shaping the future of pharma.   Dr Leonid Shapiro, Managing Partner at Candesic, will be at BitePharma Summit, taking place at Brown Rudnick LLP in Central London. Attendees will include industry professionals, healthcare experts, and academics.   Among an evening of panel discussions and presentations, one highlight will be a session chaired by Ismael Gauci on "𝗛𝗼𝘄 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗔𝗜 𝗮𝗿𝗲 𝗥𝗲𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝗣𝗵𝗮𝗿𝗺𝗮 𝗥&𝗗". A panel including Dr Shapiro will consider how we can expect to see increased partnerships between pharmaceutical firms, technology behemoths, and pioneering startups as AI revolutionizes the landscape of drug discovery and development.   Secure your free spot now: https://lnkd.in/ezC4SeKa   To find out more about Candesic’s work in this area contact Dr Leonid on LinkedIn or drop us an email at talk@candesic.com.   #BitePharma2024 #PharmaInnovation #HealthcareTech

Candesic provided commercial due diligence to the investors providing $80m of growth capital to pioneering AI drug discovery company CytoReason.   CytoReason, which offers life sciences companies AI-enabled drug discovery tools to gather data-driven and molecular-level insights to improve success in clinical trials and optimize research and development, will use the funds to expand the use of its models for different indications, grow its molecular and clinical data and open an office in Cambridge, Massachusetts, later this year.   Read more about this investment here: https://lnkd.in/ewNsjgy6   If you would like to know more about the services Candesic offers email talk@candesic.com or contact us on +44 (0)20 70967680. #dealannouncement #AI #drugdiscovery

Early notice that IPEM Paris is taking place September 9-11 at Palais des Congrès. Candesic will be there and would love to catch up with you if you are going too. Candesic Senior Partner Marc Kitten and Candesic Associate Dr Marco MAZEVET will be à Paris for an event billed as reuniting prominent field leaders in thought-provoking sessions that challenge and elevate the industry – “the global back-to-school event to maximize the quality of your connections!”. You can find out more about the event here: https://lnkd.in/g6Tif6p If you are planning to attend, ping Marc or Marco a message on LinkedIn, or email talk@candesic.com. We would love to hear from you.

As the number and complexity of clinical trials rises, participants are an increasingly precious resource. In an online piece for PharmaTimes Media Ltd, Candesic Managing Partner Dr Leonid Shapiro, Principal Floris Wentholt, and Senior Adviser Dr Joe Taylor look for an answer, and find it, in part, in changing the research toolkit. Click the link below to read about solutions which leverage technology to overcome the inherent difficulty in recruiting niche populations – and keep people actively engaged in clinical trials. https://lnkd.in/efvVtHsC Candesic has decades of expertise, and in-house scientists and doctors advising on a range of sectors including Pharma and Lifesciences, MedTech, Healthcare Services, Social Care, and Digital and Software. Want to know more? Email talk@candesic.com.

Leading mid-market private equity group Duke Street is acquiring mobile rental solutions and pre-owned imaging equipment and spare parts supplier AGITO Medical from Philips. The Candesic team led by Senior Partner Marc Kitten and supervised by Engagement Manager Fabio Ruffinoni and Senior Engagement Manager Kristoffer Kenttä provided commercial due diligence to Duke Street. Founded in 2004, AGITO offers hospitals and clinics a flexible and tailored rental service of mobile imaging equipment across CT, MR, and cath labs, with or without additional services such as staffing. Since Philips acquired AGITO in 2018, the business has grown significantly and expanded its operations to multiple international markets, delivering rental solutions across numerous countries, including Germany, France, Ireland, and the UK. AGITO is one of Europe's top three medical imaging rental businesses. James Almond, managing partner at Duke Street, said: “We are very pleased to acquire AGITO, a market-leading business that we believe represents a significant opportunity for Duke Street and our investors. Our investment in AGITO represents a classic Duke Street deal: a carve-out from a globally recognised business, acquisition of an excellent healthcare product and a talented team that we back, fuelled by an investment programme that will create value for all. “This business has great potential to scale further and cement its position as a core partner to public and private health systems across Europe.” The deal is expected to close in Q3. Candesic offers a wide range of services including strategic consulting, commercial due diligence, digital consulting and tech-enabled strategic planning. To find out more, email talk@candesic.com.

Nordic Capital is acquiring a majority stake in Sensio, a leading provider in smart monitoring technology for elderly and social care settings. The Candesic team led by Senior Partner Dr Michelle Tempest provided commercial due diligence to Nordic Capital, with Senior Engagement Manager Dr Kristoffer Kenttä supervising the project. Nordic plans to further accelerate the company’s growth, international expansion, and to continue to enhance its technology platform and products. Its flagship offering includes RoomMate, a multisensory monitor for detecting and preventing falls, and Sensio Care wireless nurse call platform, both integrated into the Sensio365 software platform. Headquartered in Norway, Sensio provides solutions to several hundred operators and care providers across Norway, Sweden, Denmark and the UK supporting around 70,000 care recipients through its technology platform. Candesic congratulates Nordic Capital on a successful transaction and looks forward to following the exciting growth journey ahead.

Candesic Senior Partner Dr Michelle Tempest will be taking to the stage again next month, as a speaker at AIMS Summit – a platform designed to foster transatlantic collaboration between medical professionals, leaders, and innovators from the United States and Ireland. The event takes place on Thursday, August 22, at the Royal College of Surgeons in Ireland (RCSI), Dublin. It will cover: ·      Academic collaboration between the US and Ireland ·      Innovation, with two sessions – one covering innovating a better health system for all, the other covering artificial intelligence ·      Mentorship. Leadership with an emphasis on wellness ·      Sport. Lessons learned in sport including leadership, team work, resilience You can read more about the summit, the evening event which follows it (AIMS PM), and the AIMS Connect workshop the following day, here: https://aimssummit.com/ Are you attending too? We would love to hear from you. Email talk@candesic.com.

Leading European private equity firm Exponent is acquiring Northern Ireland’s largest private healthcare provider Kingsbridge Healthcare Group (KHG). The Candesic team, led by Dr Leonid Shapiro, provided operational due diligence to Exponent, with an emphasis on looking at the potential for extra capacity in the business. Exponent says the investment will be used to scale the company’s operations and advance its mission to provide world-class medical services to patients across the island of Ireland. The deal marks Exponent’s eighth platform investment in Ireland, its first in Northern Ireland, and “underscores its long-standing commitment to partnering with founder-owned, market leading businesses”. KHG offers a comprehensive range of medical treatments and services in surgery and diagnostics from its four hospitals and eleven medical centres across Belfast and Ballykelly in Northern Ireland, and Sligo in the Republic of Ireland. When the deal completes, KHG co-founders Dr. Suresh Tharma and Mr. Ashok Songra will continue to hold a significant stake. Exponent is backing the incumbent management team led by Chief Executive Mark Regan. Dr. Tharma will become chair of KHG’s board. David McGovern, Partner at Exponent, said: “Kingsbridge is a special business, doing important work in a differentiated way. The strength of the company's culture and patient focus was apparent to us on our first visit to Kingsbridge Belfast. Through its high-tech facilities and thoughtful operating model, Kingsbridge is strategically well positioned to address the growing demand for healthcare services in Northern Ireland and across the island of Ireland. “We look forward to working closely with Mark and his impressive team to build on its success in the coming years by investing in its capabilities, expanding its presence, and exploring new growth initiatives. Together, we will strengthen the company’s crucial role in supporting the island’s healthcare network.”